Zobrazeno 1 - 10 of 10 pro vyhledávání: '"Kirsten M. Baecher"'
1
Do Oncologic Outcomes From Head and Neck Versus Truncal and Extremity Melanoma Differ? A Single-Institution Single-Subspecialty Experience
Autor: Michael C. Lowe, Kirsten M Baecher, Caroline R Medin, Keith A. Delman, Terrill M Flakes, Michael K. Turgeon, Geetha Mahendran
Publikováno v: Am Surg
Background Outcomes are thought to be worse in head and neck (H&N) melanoma patients. However, definitive evidence of inferior outcomes in H&N melanoma in the modern era is lacking. We sought to ascertain whether H&N melanomas carry a worse prognosis
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89db10e8e3f20707b4b3afc5e97783d3
https://doi.org/10.1177/00031348211050813
Zobrazit plný text záznamu
2
Intersection of FcγRIIB, the microbiome, and checkpoint inhibitors in antitumor immunity
Autor: Mandy L. Ford, Kirsten M Baecher
Publikováno v: Cancer Immunology, Immunotherapy. 70:3397-3404
Fc receptors (FcRs) and the microbiome are both known to have an effect on the development and progression of cancers. Checkpoint inhibitors are a novel class of therapeutics which are used to combat cancer and are integrally linked to both FcRs and
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8bb92b3b98c572b4124858db5d18ebab
https://doi.org/10.1007/s00262-021-03004-4
Zobrazit plný text záznamu
4
Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis
Autor: Amanda Ag Nijhuis, James Sun, John T. Vetto, Schelto Kruijff, Jenny Nobes, Norma E. Farrow, Russell S. Berman, Michael J Carr, Michael C. Lowe, Lisa A. Kottschade, Amod A. Sarnaik, Matthew C. Perez, Lukas B. Been, Alexander C.J. van Akkooi, Tasha M. Hughes, Ann Y. Lee, David W. Ollila, Edmund K. Bartlett, David Boulware, Jüri Teras, Hidde M. Kroon, Jeffrey M. Farma, Marc Moncrieff, Jonathan S. Zager, Yun Song, Jane Yc Hui, Tina J. Hieken, David E. Gyorki, Martin D. Fleming, Kristy K. Broman, Giorgos C. Karakousis, Lesly A. Dossett, Jan Mattsson, Dennis A Kirichenko, Jeremiah L. Deneve, Dale Han, Jennifer Downs, Georgia M. Beasley, Kirsten M Baecher, Harvey Chai, John F. Thompson, Roger Olofsson Bagge, Jill S. Frank, Vernon K. Sondak, Avinash Sharma, Roland M. Teras, Emma H. A. Stahlie
Publikováno v: Journal of the american college of surgeons, 232(4), 424-431. ELSEVIER SCIENCE INC
Background: In sentinel lymph node (SLN)-positive melanoma, two randomized trials demonstrated equivalent melanoma-specific survival with nodal surveillance vs completion lymph node dissection (CLND). Patients with microsatellites, extranodal extensi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bef2f9c0bbdaccc7182dcea4c2d35c29
https://research.rug.nl/en/publications/79ae968e-8f0b-4b47-861f-6dbc4851e58e
Zobrazit plný text záznamu
5
Abstract 594: FcγRIIB expressed on activated CD8+ T cells restrains T cell responsiveness to αPD-1 immune checkpoint blockade in melanoma patients
Autor: Kelsey B. Bennion, Marvi Tariq, Kirsten M. Baecher, Chrystal M. Paulos, Ragini Kudchadkar, Michael C. Lowe, Mandy L. Ford
Publikováno v: Cancer Research. 82:594-594
In this study, we show that FcγRIIB on the surface of CD8+ T cells reduces responsiveness to αPD-1 antibody in melanoma patients, and we suggest therapeutic strategies to improve CD8+ T cell response to PD-1 blockade. Immune checkpoint blockade (IC
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::913082f7108781ed8c2c3e9a182019fb
https://doi.org/10.1158/1538-7445.am2022-594
Zobrazit plný text záznamu
7
Intersection of FcγRIIB, the microbiome, and checkpoint inhibitors in antitumor immunity
Autor: Kirsten M, Baecher, Mandy L, Ford
Publikováno v: Cancer immunology, immunotherapy : CII. 70(12)
Fc receptors (FcRs) and the microbiome are both known to have an effect on the development and progression of cancers. Checkpoint inhibitors are a novel class of therapeutics which are used to combat cancer and are integrally linked to both FcRs and
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f68a7ab30b3b5ddbade43e95e01ad9de
https://pubmed.ncbi.nlm.nih.gov/34241677
Zobrazit plný text záznamu
8
The impact of axillary node surgery on outcomes following immediate breast reconstruction
Autor: Albert Losken, Alexandra M. Hart, Kirsten M Baecher, Toncred M. Styblo, Grant W. Carlson, Nusaiba Baker
Publikováno v: The breast journalREFERENCES. 26(11)
Immediate breast reconstruction (IBR) has become the most common method for postmastectomy reconstruction. Axillary lymph node dissection is performed for the staging of patients, but the impact of IBR with nodal surgery on postoperative complication
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a01a4a0ec5640700f0df5b318f2ec295
https://pubmed.ncbi.nlm.nih.gov/33051937
Zobrazit plný text záznamu
10
Current Opinion on the Oncoplastic Approach in the USA
Autor: Fracesco Maria Egro, Albert Losken, Sameer M. Kapadia, Toncred M. Styblo, Grant W. Carlson, Kirsten M Baecher
Publikováno v: The Breast Journal. 22:437-441
The management of women with breast cancer who wish to preserve their breasts often includes partial reconstruction at the time of tumor resection. This is referred to as the oncoplastic approach and has been shown to improve outcomes. The purpose of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::450ca318814587498d231ae3085923e0
https://doi.org/10.1111/tbj.12592
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje